comprehensive -WSS

comprehensive

author：hotspot 2025-09-30 22:27:32 - browse：35569

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

WSS

Microsoft strikes partnership with Duke Health to advance health AI

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

IVF, abortion rights issues kick off Biden’s State of the Union

What it’s like to watch children die of measles

NEJM study link tiny plastics in blood vessels to heart problems

Influencer to be charged after chaos erupts in New York City's Union Square

leisure time

comprehensive

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

The drug industry sees a key ally in the Senate prevail

Peter Hotez and the public health issue of online harassment

'Ancient DNA,' 23andMe reveal African American ancestries

Sports medicine is finally prioritizing gender equality

A cyberattack has disrupted hospitals and health care in several states

Heart attack and stroke risk calculators need revising

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

What does generative AI mean for health care? We asked experts

Nearly two

focus

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

The Readout: Amylyx, Alumis, and Lundbeck drug updates

focus

entertainment

entertainment

focus